Placeholder text

The Role of Biomarkers in Systemic Scleroderma

The Role of Biomarkers in Systemic Scleroderma

0 - Default Title
Description
Systemic scleroderma is a highly heterogeneous autoimmune disease accompanied by progressive fibrosis of the skin and internal organs. In recent years, special attention has been paid to the role of biomarkers in the diagnosis of profibrous processes, which allows for the detection of early stages of the disease, predicting the severity and effectiveness of therapy. Key markers include TGF-ß, IL-6, IL-13, IL-17, CXCL4, MMP-7, TIMP-1, KL-6, microRNA, and new molecules such as LOXL2 and periostin. The integrated use of biomarkers provides early diagnosis, risk stratification, and personalized patient management.
Product details
Binding:
Paperback
Number of Pages:
52
Release Date:
2025-12-02
Publication Date:
2025-12-02
Publisher:
GlobeEdit
Languages:
Original: English
ISBN10:
6209365906
ISBN13:
9786209365904
GPSR Manufacturer Reference:
Weight:
96 g
Height:
150 cm
Width:
220 cm
Thickness:
4 cm
Currently sold out